-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SD5h+fkEqPUMlu2F++UgPjPyUbd8CQAKDehhKUpVpG8bsveooBp/tnDtVghduLhL eg+U9P1/L+LV253lkFnTjg== 0001092307-02-000087.txt : 20020531 0001092307-02-000087.hdr.sgml : 20020531 20020531141210 ACCESSION NUMBER: 0001092307-02-000087 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020531 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: RADIOLOGIX INC CENTRAL INDEX KEY: 0001031329 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 752648089 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-55929 FILM NUMBER: 02667645 BUSINESS ADDRESS: STREET 1: 3600 CHASE TOWER STREET 2: 2200 ROSS AVENUE CITY: DALLAS STATE: TX ZIP: 75201 BUSINESS PHONE: 2143032776 MAIL ADDRESS: STREET 1: 901 MAIN ST STREET 2: SUITE 2301 CITY: DALLAS STATE: TX ZIP: 75202 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN PHYSICIAN PARTNERS INC DATE OF NAME CHANGE: 19970523 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: TAUNUS CORP CENTRAL INDEX KEY: 0001092307 IRS NUMBER: 134060471 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 31 W 52ND STREET CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2124698000 MAIL ADDRESS: STREET 1: 31 W 52ND STREET CITY: NEW YORK STATE: NY ZIP: 10019 SC 13G/A 1 radio2.txt QUARTERLY FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ------------ SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 3) Radiologix, Inc. ---------------------------- (Name of issuer) Common Stock, $0.0001 par value per share ----------------------------------------- (Title of class of securities) 75040K109 ------------------------------- (CUSIP number) May 29, 2002 ----------------------------------------------- (Date of Event which requires filing of this Statement) Check the appropriate box to designate the rule pursuant to which this schedule is filed: |_| Rule 13d-1 (b) |X| Rule 13d-1 (c) |_| Rule 13d-1 (d) CUSIP No. 75040K109 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Taunus Corp. --------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) |_| 3 SEC USE ONLY --------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware --------------------- NUMBER OF SHARES 5 SOLE VOTING POWER 0 BENEFICIALLY OWNED BY SHARED VOTING POWER 6 2,048,809 EACH REPORTING SOLE DISPOSITIVE POWER 7 0 PERSON WITH SHARED DISPOSITIVE POWER 8 2,048,809 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,048,809* --------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |_| 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.1%** --------------------- 12 TYPE OF REPORTING PERSON HC, CO --------------------- * Included in this figure are the securities reported by DB Capital Partners SBIC, L.P. on the following cover page. ** Included in this percentage is the percentage of securities reported by DB Capital Partners SBIC, L.P. on the following cover page. CUSIP No. 75040K109 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON DB Capital Partners SBIC, L.P. ------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) |_| 3 SEC USE ONLY --------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION State of Delaware --------------------- NUMBER OF SHARES 5 SOLE VOTING POWER 0 BENEFICIALLY OWNED BY SHARED VOTING POWER 6 2,048,809 EACH SOLE DISPOSITIVE POWER REPORTING 7 0 PERSON WITH SHARED DISPOSITIVE POWER 8 2,048,809 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,048,809 --------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |_| 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.1% --------------------- 12 TYPE OF REPORTING PERSON PN --------------------- CUSIP No. 75040K109 Item 1(a). Name of Issuer: Radiologix, Inc. (the "Issuer"). Item 1(b). Address of Issuer's Principal Executive Offices: The address of the Issuer's principal executive offices is 3600 Chase Tower, 2200 Ross Avenue, Dallas, Texas, 75201. Item 2(a). Name of Person Filing: This statement is filed on behalf of Taunus Corp. ("Taunus") and DB Capital Partners SBIC, L.P. ("DBCP") (Taunus and DBCP together, the "Reporting Persons"). Item 2(b). Address of Principal Business Office or, if none, Residence: The principal place of business of Taunus is 31 West 52nd Street, New York, New York, 10019. The principal place of business of DBCP is 31 West 52nd Street, New York, New York, 10019. Item 2(c). Citizenship: The citizenship of each of the Reporting Persons is set forth on the applicable cover page. Item 2(d). Title of Class of Securities: The title of the securities is common stock $0.0001 par value per share (the "Common Stock"). Item 2(e). CUSIP Number: The CUSIP number of the Common Stock is set forth on each cover page. Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: (a) |_| Broker or dealer registered under section 15 of the Act; (b) |_| Bank as defined in section 3(a)(6) of the Act; (c) |_| Insurance Company as defined in section 3(a)(19) of the Act; (d) |_| Investment Company registered under section 8 of the Investment Company Act of 1940; (e) |_| An investment adviser in accordance with Rule 13d-1 (b)(1)(ii)(E); (f) |_| An employee benefit plan, or endowment fund in accordance with Rule 13d-1 (b)(1)(ii)(F); (g) |_| A parent holding company or control person in accordance with Rule 13d-1 (b)(1)(ii)(G); (h) |_| A savings association as defined in section 3(b) of the Federal Deposit Insurance Act; (i) |_| A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940; (j) |_| Group, in accordance with Rule 13d-1 (b)(1)(ii)(J). If this statement is filed pursuant to Rule 13d-1 (c), check this box. |X| Item 4. Ownership. (a) Amount beneficially owned: Each of the Reporting Persons owns the amount of the Common Stock as set forth on the applicable cover page. (b) Percent of class: Each of the Reporting Persons owns the percentage of the Ordinary Shares as set forth on the applicable cover page. (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: Each of the Reporting Persons has the sole power to vote or direct the vote of the Common Stock as set forth on the applicable cover page. (ii) shared power to vote or to direct the vote: Each of the Reporting Persons has the shared power to vote or direct the vote of the Common Stock as set forth on the applicable cover page. (iii) sole power to dispose or to direct the disposition of: Each of the Reporting Persons has the sole power to dispose or direct the disposition of the Common Stock as set forth on the applicable cover page. (iv) shared power to dispose or to direct the disposition of: Each of the Reporting Persons has the shared power to dispose or direct the disposition of the Common Stock as set forth on the applicable cover page. Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. The Common Stock was acquired by DBCP, which is an indirect wholly-owned subsidiary of Taunus. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: May 31, 2002 TAUNUS CORP. By: /s/ James T. Byrne, Jr. --------------------------------- Name: James T. Byrne, Jr. Title: Secretary EXHIBIT 2 Consent of DB Capital Partners SBIC, L.P. The undersigned agrees that the Schedule 13G executed by Taunus Corp. to which this statement is attached as an exhibit is filed on behalf of Taunus Corp. and DB Capital Partners SBIC, L.P. pursuant to Rule 13d-1(k)(1) of the Securities Exchange Act of 1934. Dated: May 31, 2002 DB Capital Partners SBIC, L.P. By: /s/ Heide Silverstein ------------------------------- Name: Heide Silverstein Title: Secretary -----END PRIVACY-ENHANCED MESSAGE-----